The frequency of corticospinal tract (CST) T2/FLAIR hyperintensity in disorders with neuroglial antibodies is unclear. Herein, we retrospectively reviewed brain MRIs of 101 LGI1-antibody encephalitis patients, and observed CST hyperintensity in 30/101 (30%). It was mostly bilateral (93%), not associated with upper motor neuron signs/symptoms (7%), and frequently decreased over time (39%). In a systematic review including patients with other neuroglial antibodies, CST hyperintensity was reported in 110 with neuromyelitis optica (94%), myelin oligodendrocyte glycoprotein-associated disease (2%), Ma2-antibody (3%) and GAD65-antibody paraneoplastic neurological syndrome (1%). CST hyperintensity is not an infrequent finding in LGI1-Ab encephalitis and other disorders with neuroglial antibodies.

Campetella, L., Villagrán-García, M., Farina, A., Benaiteau, M., Iorio, R., Calabresi, P., Vogrig, A., Versace, S., Ciano-Petersen, N. L., Bicilli Brotelle, E., Branger, P., Verlut, C., Langner-Lemercier, S., Leclancher, A., Duwicquet, C., Charif, M., Kerschen, P., Capet, N., Renard, D., Chanson, E., Rafiq, M., Tyvaert, L., Joubert, B., Cotton, F., Honnorat, J., Muñiz-Castrillo, S., Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies, <<JOURNAL OF NEUROIMMUNOLOGY>>, 2024; 390 (April): N/A-N/A. [doi:10.1016/j.jneuroim.2024.578346] [https://hdl.handle.net/10807/302137]

Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies

Iorio, Raffaele;Calabresi, Paolo;
2024

Abstract

The frequency of corticospinal tract (CST) T2/FLAIR hyperintensity in disorders with neuroglial antibodies is unclear. Herein, we retrospectively reviewed brain MRIs of 101 LGI1-antibody encephalitis patients, and observed CST hyperintensity in 30/101 (30%). It was mostly bilateral (93%), not associated with upper motor neuron signs/symptoms (7%), and frequently decreased over time (39%). In a systematic review including patients with other neuroglial antibodies, CST hyperintensity was reported in 110 with neuromyelitis optica (94%), myelin oligodendrocyte glycoprotein-associated disease (2%), Ma2-antibody (3%) and GAD65-antibody paraneoplastic neurological syndrome (1%). CST hyperintensity is not an infrequent finding in LGI1-Ab encephalitis and other disorders with neuroglial antibodies.
2024
Inglese
Campetella, L., Villagrán-García, M., Farina, A., Benaiteau, M., Iorio, R., Calabresi, P., Vogrig, A., Versace, S., Ciano-Petersen, N. L., Bicilli Brotelle, E., Branger, P., Verlut, C., Langner-Lemercier, S., Leclancher, A., Duwicquet, C., Charif, M., Kerschen, P., Capet, N., Renard, D., Chanson, E., Rafiq, M., Tyvaert, L., Joubert, B., Cotton, F., Honnorat, J., Muñiz-Castrillo, S., Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies, <<JOURNAL OF NEUROIMMUNOLOGY>>, 2024; 390 (April): N/A-N/A. [doi:10.1016/j.jneuroim.2024.578346] [https://hdl.handle.net/10807/302137]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/302137
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact